Analysts predict that UnitedHealth Group Inc (NYSE:UNH) will announce earnings per share (EPS) of $2.92 for the current quarter, according to Zacks. Six analysts have made estimates for UnitedHealth Group’s earnings. The lowest EPS estimate is $2.83 and the highest is $3.00. UnitedHealth Group posted earnings per share of $2.37 during the same quarter last year, which indicates a positive year-over-year growth rate of 23.2%. The company is scheduled to report its next quarterly earnings results on Tuesday, April 17th.
According to Zacks, analysts expect that UnitedHealth Group will report full-year earnings of $12.47 per share for the current fiscal year, with EPS estimates ranging from $12.00 to $12.60. For the next fiscal year, analysts expect that the company will report earnings of $14.01 per share, with EPS estimates ranging from $13.38 to $14.48. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm’s revenue was up 9.5% compared to the same quarter last year. During the same period last year, the business posted $2.11 earnings per share.
Several equities research analysts have recently issued reports on the company. Deutsche Bank raised their price target on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Wells Fargo & Co reissued an “outperform” rating and set a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. Citigroup lifted their target price on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research report on Wednesday, October 18th. Finally, BMO Capital Markets started coverage on UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 target price on the stock. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $243.22.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the transaction, the director now owns 76,637 shares of the company’s stock, valued at approximately $18,881,824.06. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 53,853 shares of company stock valued at $12,358,508. Corporate insiders own 0.89% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in UNH. Retirement Systems of Alabama raised its stake in shares of UnitedHealth Group by 10.0% in the second quarter. Retirement Systems of Alabama now owns 704,238 shares of the healthcare conglomerate’s stock valued at $130,580,000 after acquiring an additional 63,998 shares during the last quarter. Chicago Partners Investment Group LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $189,000. Palladium Partners LLC raised its stake in shares of UnitedHealth Group by 1.2% in the second quarter. Palladium Partners LLC now owns 39,876 shares of the healthcare conglomerate’s stock valued at $7,394,000 after acquiring an additional 485 shares during the last quarter. Founders Financial Securities LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $213,000. Finally, WealthTrust Axiom LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $203,000. Hedge funds and other institutional investors own 86.24% of the company’s stock.
Shares of UnitedHealth Group (UNH) traded down $0.41 during trading hours on Friday, hitting $231.47. The stock had a trading volume of 563,305 shares, compared to its average volume of 3,776,244. The firm has a market capitalization of $224,707.38, a P/E ratio of 21.60, a P/E/G ratio of 1.35 and a beta of 0.70. UnitedHealth Group has a 12 month low of $156.49 and a 12 month high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.
ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Inc (UNH) Expected to Announce Earnings of $2.92 Per Share” was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.thelincolnianonline.com/2018/02/12/unitedhealth-group-inc-unh-expected-to-announce-earnings-of-2-92-per-share-updated.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.